Arcus biosciences to participate in two upcoming investor conferences

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that its management team will participate in the following upcoming investor conferences in march: leerink global healthcare conference 2025 date: wednesday, march 12th, 2025 location: miami beach, fl format: fireside chat & 1x1 meetings time: 8:00 a.m. et barclays 27th.
RCUS Ratings Summary
RCUS Quant Ranking